Brooklyn Investment Group Acquires 124 Shares of Agilent Technologies, Inc. (NYSE:A)

Brooklyn Investment Group lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 7.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,887 shares of the medical research company’s stock after acquiring an additional 124 shares during the period. Brooklyn Investment Group’s holdings in Agilent Technologies were worth $280,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Menard Financial Group LLC boosted its stake in Agilent Technologies by 1.6% during the 2nd quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock valued at $628,000 after purchasing an additional 77 shares during the last quarter. McAdam LLC raised its position in Agilent Technologies by 3.1% in the 3rd quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock valued at $376,000 after buying an additional 77 shares during the last quarter. Brown Brothers Harriman & Co. grew its stake in shares of Agilent Technologies by 13.5% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock worth $96,000 after acquiring an additional 77 shares in the last quarter. Global Retirement Partners LLC raised its holdings in shares of Agilent Technologies by 3.2% in the third quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock valued at $382,000 after purchasing an additional 79 shares during the last quarter. Finally, Rovin Capital UT ADV lifted its position in shares of Agilent Technologies by 1.6% during the third quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after purchasing an additional 81 shares in the last quarter.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $134.35 on Wednesday. Agilent Technologies, Inc. has a fifty-two week low of $124.10 and a fifty-two week high of $155.35. The firm’s fifty day moving average price is $137.74 and its 200-day moving average price is $137.43. The stock has a market cap of $38.60 billion, a P/E ratio of 27.87, a price-to-earnings-growth ratio of 5.89 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.74%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date is Tuesday, December 31st. Agilent Technologies’s dividend payout ratio (DPR) is currently 19.50%.

Insider Buying and Selling

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Analysts Set New Price Targets

A has been the topic of several recent analyst reports. Sanford C. Bernstein dropped their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday. Evercore ISI boosted their price objective on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Wells Fargo & Company started coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price target on the stock. TD Cowen raised their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Finally, Bank of America increased their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $144.07.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.